Medical/Pharmaceuticals
Peijia Medical Engages Professor Saibal Kar as Exclusive Consultant
SUZHOU, China, Sept. 6, 2021 /PRNewswire/ -- Peijia Medical Limited (HKEX: 9996) is pleased to announceSaibal Kar MD, FACC, FSCAI, board-certified interventional cardiologist has agreed to become our exclusive consultant in China to advise the research and development of our Mitral Transcatheter E...
2021-09-06 13:44
4564
Kintor Pharma Included in Hong Kong Stock Connect Program
SUZHOU, China, Sept. 6, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the company's stock has been included in the Hong Kong Stock Conn...
2021-09-06 11:30
4744
CStone Pharmaceuticals Included in the Hong Kong Stock Connect
SUZHOU, China, Sept. 6, 2021 /PRNewswire/ -- CStone Pharmaceuticals (HKEX: 2616, "CStone" or the "Company"), a leading biopharmaceutical company focused on researching, developing and commercializing innovative immuno-oncology therapies and precision medicines, announced that the Company has been...
2021-09-06 11:30
4994
Lunit AI Receives HSA Approval, Now Commercially Available in Singapore
* Lunit AI products for analyzing chest X-ray and mammograms now approved to support medical professionals ofSingapore, by detecting suspicious lesions with 96-99% accuracy * Applied in one of Singapore's leading healthcare center, with positive feedback from the users SEOUL, South Korea, Sep...
2021-09-06 09:30
2560
GeneQuantum and BrighGene sign agreement for development of antibody immune agonist conjugates
SUZHOU, China, Sept. 5, 2021 /PRNewswire/ -- GeneQuantum Healthcare (Suzhou) Co.,Ltd. (hereinafter referred to as "GeneQuantum") and BrighGene Biomedical (Suzhou) Co.,Ltd. (hereinafter referred to as "BrighGene ") signed a co-development agreement for antibody immune agonist conjugate (AIAC), GQ1...
2021-09-06 09:00
1988
Gannex Announces Clinical Trial Application of ASC42, an FXR Agonist, for Treatment of Primary Biliary Cholangitis Accepted by China NMPA
SHANGHAI, Sept. 6, 2021 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that the clinical trial application of ASC42 to treat patients with primary biliary cholangitis (PBC) has been accepted for review by China National Medical ...
2021-09-06 08:30
4088
AffaMed Therapeutics Enters into Strategic Partnership Agreement with Beijing Tiantan Hospital and Infinite Brain Technologies to Promote Digital Therapy in Neurological Diseases
BEIJING, Sept. 5, 2021 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to addressing critical unmet medical needs in ophthalmic, neurological and psychiatric disorders, announced during the recent "China International Trade in Servi...
2021-09-06 08:00
1789
WuXi AppTec Receives AA ESG Rating from MSCI
SHANGHAI, Sept. 5, 2021 /PRNewswire/ -- WuXi AppTec ("the Company") is pleased to announce that Morgan Stanley Capital International ("MSCI") has upgraded its MSCI ESG Rating to AA. The Company also received outstanding scores in the areas of "corporate governance" and "product safety and quality...
2021-09-06 08:00
3683
The National Medical Products Administration (NMPA) issues product license for Abiraterone acetate 250 mg, Bioequivalance study conducted in India by Accutest Research Laboratories (I) Pvt. Ltd., one of the Top Indian CRO
BEIJING and MUMBAI, India, Sept. 6, 2021 /PRNewswire/ -- National Medical
Products Administration
2021-09-06 08:00
2816
Avidity Science Announces Agreement to Divest Lab Products & Harford Systems
WATERFORD, Wis., Sept. 4, 2021 /PRNewswire/ -- Avidity Science, a worldwide leader in life science research tools, today announces it has sold its subsidiaries of Lab Products, LLC. and Harford Systems, LLC. to Gen Cap America, Inc. ("Gen Cap"), a private equity firm focused on lower middle marke...
2021-09-04 00:00
5582
BGI safeguards Ethiopia-China Route with airport COVID-19 testing lab
SHENZHEN, China, Sept. 3, 2021 /PRNewswire/ -- From April to August, 2021, BGI's COVID-19 testing lab has helped 5,500 Chinese travelers safely fly out of the Addis Ababa Bole International Airport. In April, BGI set up the "Huo-Yan" laboratory, a COVID-19 testing lab, at the airport for pass...
2021-09-03 21:16
4297
PharmAbcine Receives HREC Clearance for Phase II Trial of Olinvacimab and Pembrolizumab in mTNBC
DAEJEON, South Korea, Sept. 3, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company has received Human Research Ethics Committee (HREC) clearance to commence the Phase II c...
2021-09-03 20:00
2590
Arctic Vision Obtains China IND Clearance for Phase III Study of ARVN003, the First in China for Presbyopia Treatment
SHANGHAI, Sept. 2, 2021 /PRNewswire/ -- Arctic Vision, a China-based clinical-stage ophthalmology company with a leading portfolio of breakthrough technologies, today announced the clearance of the Investigational New Drug (IND) application for Phase III study of ARVN003 (pilocarpine microdose o...
2021-09-03 08:00
2615
Clinical trial provides preliminary evidence of a cure for myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) and Long Covid
BURLINGAME, Calif., Sept. 3, 2021 /PRNewswire/ -- Cortene Inc. announces publication of its InTiME clinical trial in which a short subcutaneous infusion of its experimental drug, CT38, achieved sustained symptom improvement in ME/CFS. The company intends to test CT38 in Long Covid, the post-acut...
2021-09-03 06:00
2445
Angel Yeast Launches Patented Saccharomyces Boulardii Bld-3, a Strain of Yeast Probiotic Effective Against Diarrhea
YICHANG, China, Sept. 2, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd
2021-09-02 22:43
6242
Insilico Medicine Appoints the Former Chief Medical Officer of Schering Plough, Dr. Robert Spiegel, MD, FACP, as acting Chief Medical Officer (CMO) to Oversee the Clinical Translation of its Preclinical Pipeline Assets
SHANGHAI and NEW YORK, Sept. 2, 2021 /PRNewswire/ -- Insilico Medicine, an end-to-end AI-powered drug discovery company, today announced the appointment of Robert Spiegel as acting CMO to oversee the clinical translation of its preclinical pipeline assets. Dr. Spiegel brings over 35 years of exte...
2021-09-02 21:00
4367
Rapid acceleration of medical education for Japan's medical students using VR - NHK special feature published online
TOKYO, Sept. 2, 2021 /PRNewswire/ -- At many Japanese institutions offering medical education, medical students are unable to attend clinical practice due to the spread of COVID-19, denying them the experience of valuable opportunities to learn. Efforts by Jolly Good and Nippon Medical School to...
2021-09-02 21:00
2737
I-Mab Added to FTSE Russell Global Equity Index Series
SHANGHAI and GAITHERSBURG, Md., Sept. 2, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that I-Mab will be added to the following FTSE Global Eq...
2021-09-02 20:00
6697
High-end Global Computed Tomography Purchases to Propel the High-end CT Segment Revenue
CT market is expected to reach $6.14 billion by 2025, registering steady growth at a CAGR of 8.1%, finds Frost & Sullivan SANTA CLARA, Calif., Sept. 2, 2021 /PRNewswire/ -- An estimated 375 million computed tomography (CT) procedures are carried out globally each year, increasing annually by 3%–...
2021-09-02 16:02
2062
Elekta acquires Turkish distributor to strengthen market position
STOCKHOLM, Sept. 2, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has acquired its long-time partner and Turkish distributor of neurosurgery solutions, Özyürek Mümessillik ve Dış Ticaret A.Ş. (Özyürek A.Ş.). The acquisition will improve Elekta's market access in the region and ...
2021-09-02 14:16
4957
Week's Top Stories
Most Reposted
Visa redefines its role in travel with the global expansion of Visa Destinations
[Picked up by 336 media titles]
2026-06-30 10:00Sustainable Tourism Academy Celebrates 3,000-User Milestone in First Year with ASEAN Expansion and New Language Support
[Picked up by 323 media titles]
2026-06-29 12:41
Agoda rolls out suite of new features focused on real-time updates and smarter trip planning
[Picked up by 321 media titles]
2026-07-01 10:00
On-us Brings Real-Time Smart E-Vouchers to Google Wallet, Giving Marketers a Live Read on Customer Behavior
[Picked up by 319 media titles]
2026-06-30 11:00
Avnet Brings Ecosystem Together to Scale Edge AI in Singapore
[Picked up by 305 media titles]
2026-06-30 09:00Most Read
JINRO, the World's No. 1 Soju Brand, Partners with V of BTS
2026-07-03 08:00
16418
/UPDATE TO VIDEO -- New York Stock Exchange/
2026-07-01 01:36
7712
NYSE Content Update: Mobility Global Marks First Day as Public Company
2026-07-01 21:22
7348
Vietnam: TotalEnergies ENEOS Commissions 28 MWp Rooftop Solar Project at Samsung Electronics HCMC CE Complex
2026-07-03 17:10
6972
/C O R R E C T I O N -- Nuvei/
2026-07-02 23:01
6663